Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples